Literature DB >> 12152917

Diabetes mellitus and hypertension: key risk factors for kidney disease.

Janice P Lea1, Susanne B Nicholas.   

Abstract

The incidence of end-stage renal disease (ESRD) in the US is rising at an alarming rate, with the largest increase among African-American populations. The key risk factors for kidney disease are hypertension and diabetes, which are both becoming more prevalent in the US, and particularly in African Americans. Although African Americans make up 12.6% of the US population, the incidence of diabetes-related ESRD is four times higher than for whites, and the prevalence of ESRD due to hypertension is twice that of white patients. Approximately 30 to 40% of all patients with diabetes will develop nephropathy and many will progress to ESRD, necessitating dialysis or kidney transplantation. Recent studies in patients with type 2 diabetes indicate a significant delay in progression or development of diabetic nephropathy following blockade of the renin-angiotensin-aldosterone system with the use of angiotensin receptor antagonists. Early intervention in patients with hypertension is necessary to prevent kidney damage, and data from the African American Study of Kidney Disease and Hypertension suggest that angiotensin-converting enzyme inhibitors are effective in this population. Although African-American patients receiving hemodialysis appear to have increased survival compared with whites, racial factors and poor access to medical care contribute to the increased risk of kidney disease in minorities. A concerted effort is necessary to raise awareness in minority populations and provide strategies for prevention and early treatment thereby attenuating the increasing prevalence of kidney failure in these groups.

Entities:  

Mesh:

Year:  2002        PMID: 12152917      PMCID: PMC2594170     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  42 in total

1.  High prevalence of albuminuria among African-Americans with short duration of diabetes.

Authors:  L M Thaler; I M El-Kebbi; D C Ziemer; D L Gallina; V G Dunbar; L S Phillips
Journal:  Diabetes Care       Date:  1998-09       Impact factor: 19.112

2.  Effects of diet and sodium intake on blood pressure: subgroup analysis of the DASH-sodium trial.

Authors:  W M Vollmer; F M Sacks; J Ard; L J Appel; G A Bray; D G Simons-Morton; P R Conlin; L P Svetkey; T P Erlinger; T J Moore; N Karanja
Journal:  Ann Intern Med       Date:  2001-12-18       Impact factor: 25.391

3.  Racial differences in the incidence of treatment for end-stage renal disease.

Authors:  S G Rostand; K A Kirk; E A Rutsky; B A Pate
Journal:  N Engl J Med       Date:  1982-05-27       Impact factor: 91.245

4.  Risk factors for microalbuminuria in black americans with newly diagnosed type 2 diabetes.

Authors:  K A Kohler; W M McClellan; D C Ziemer; D G Kleinbaum; J R Boring
Journal:  Am J Kidney Dis       Date:  2000-11       Impact factor: 8.860

5.  Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: a report from the African American Study of Kidney Disease (AASK) Trial. AASK Pilot Study Investigators.

Authors:  A Fogo; J A Breyer; M C Smith; W H Cleveland; L Agodoa; K A Kirk; R Glassock
Journal:  Kidney Int       Date:  1997-01       Impact factor: 10.612

6.  Renal function change in hypertensive members of the Multiple Risk Factor Intervention Trial. Racial and treatment effects. The MRFIT Research Group.

Authors:  W G Walker; J D Neaton; J A Cutler; R Neuwirth; J D Cohen
Journal:  JAMA       Date:  1992-12-02       Impact factor: 56.272

Review 7.  Prevalence of complications and response to different treatments of hypertension in African Americans and white Americans in the U.S..

Authors:  K A Jamerson
Journal:  Clin Exp Hypertens       Date:  1993-11       Impact factor: 1.749

8.  The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

Authors:  S Klahr; A S Levey; G J Beck; A W Caggiula; L Hunsicker; J W Kusek; G Striker
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

9.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245

10.  The African American Study of Kidney Disease and Hypertension (AASK): new findings.

Authors:  D A Sica; J G Douglas
Journal:  J Clin Hypertens (Greenwich)       Date:  2001 Jul-Aug       Impact factor: 3.738

View more
  35 in total

1.  Association of kidney function and albuminuria with prevalent and incident hypertension: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Minxuan Huang; Kunihiro Matsushita; Yingying Sang; Shoshana H Ballew; Brad C Astor; Josef Coresh
Journal:  Am J Kidney Dis       Date:  2014-08-21       Impact factor: 8.860

2.  Marital differences in blood pressure and the risk of hypertension among Polish men.

Authors:  Anna Lipowicz; Monika Lopuszanska
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  Post-transplant diabetes mellitus: risk reduction strategies in the elderly.

Authors:  Alain Duclos; Lawrence M Flechner; Charles Faiman; Stuart M Flechner
Journal:  Drugs Aging       Date:  2006       Impact factor: 3.923

4.  Optimism is associated with chronic kidney disease and rapid kidney function decline among African Americans in the Jackson Heart Study.

Authors:  LáShauntá M Glover; Crystal Butler-Williams; Loretta Cain-Shields; Allana T Forde; Tanjala S Purnell; Bessie Young; Mario Sims
Journal:  J Psychosom Res       Date:  2020-10-06       Impact factor: 3.006

5.  Associations between blood cadmium concentration and kidney function in the U.S. population: Impact of sex, diabetes and hypertension.

Authors:  Jessica M Madrigal; Ana C Ricardo; Victoria Persky; Mary Turyk
Journal:  Environ Res       Date:  2018-11-06       Impact factor: 6.498

6.  Increased body mass index is a risk factor for end-stage renal disease in the Chinese Singapore population.

Authors:  Quan-Lan Jasmine Lew; Tazeen Hasan Jafar; Mohammad Talaei; Aizhen Jin; Khuan Yew Chow; Jian-Min Yuan; Woon-Puay Koh
Journal:  Kidney Int       Date:  2017-05-18       Impact factor: 10.612

7.  Renal Function and Bone Loss in a Cohort of Afro-Caribbean Men.

Authors:  Allison L Kuipers; Heartley Egwuogu; Rhobert W Evans; Alan L Patrick; Ada Youk; Clareann H Bunker; Joseph M Zmuda
Journal:  J Bone Miner Res       Date:  2015-06-16       Impact factor: 6.741

Review 8.  Should we treat prehypertension in diabetes? What are the cons?

Authors:  Ehud Grossman
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

9.  Associations between urinary cadmium levels, blood pressure, and hypertension: the ESTEBAN survey.

Authors:  Alexandre Vallée; Amélie Gabet; Clémence Grave; Jacques Blacher; Valérie Olié
Journal:  Environ Sci Pollut Res Int       Date:  2020-01-16       Impact factor: 4.223

10.  Development of risk maps to minimize uranium exposures in the Navajo Churchrock mining district.

Authors:  Jamie L deLemos; Doug Brugge; Miranda Cajero; Mallery Downs; John L Durant; Christine M George; Sarah Henio-Adeky; Teddy Nez; Thomas Manning; Tommy Rock; Bess Seschillie; Chris Shuey; Johnnye Lewis
Journal:  Environ Health       Date:  2009-07-09       Impact factor: 5.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.